Scisparc signs agreement for the supply of cbd-rich cannabis oil for its clinical trial on children with autism spectrum disorder

The cannabis oil will be use d as a part of the c ompany ' s proprietary sci-210 treatment combination of cbd and cannamide™

SPRC Ratings Summary

SPRC Quant Ranking